About: Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1993

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1993 (uk) im Januar 1993 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1993 (ast) artikull shkencor i botuar më 01 janar 1993 (sq) scientific article published on 01 January 1993 (en)
publication date	wds:Q72066829-20BA93E6-5369-4B55-B11A-F31C7B44ACF4
publication date	1993-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q72066829-2571FC03-5ED2-44A0-9E04-36A268455519 wds:Q72066829-55F76619-A19A-4C98-843D-DDA858747BC2 wds:Q72066829-A864EB9F-3862-4653-8CD7-5D6C0E91FA5F wds:Q72066829-B7EAFB84-F268-487B-947C-CCD26AE5C638 wds:Q72066829-C436E577-8E24-4D2E-ABB0-E0D3D70610FD wds:Q72066829-E8899086-54AC-431B-830D-47A402095CFF
author name string	Daurès JP Michel FB Pujol H Pujol JL Grenier J Daver A
rdfs:label	Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer (en) Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer (nl) Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer (sq)
skos:prefLabel	Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer (en) Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer (nl) Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer (sq)
name	Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer (en) Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer (nl) Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer (sq)
title	wds:Q72066829-9FB36ED3-C1C6-431E-BB77-E21A40174835
title	Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer (en)
page(s)	wds:Q72066829-64FE1219-C298-4416-A9FF-A81CA33FDF24
page(s)	61-66
instance of	wds:Q72066829-1C944B18-D071-499E-AE01-C1C0E2A88664
instance of	scholarly article
main subject	wds:Q72066829-0A483B89-0330-48C0-9255-A2471222D1DC
main subject	lung cancer
PubMed ID	wds:Q72066829-9B1F7550-0163-48B2-90C7-648CD50CCA81
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7677981
PubMed ID	7677981
published in	wds:Q72066829-C6FBBEB0-05D0-47EC-B0BA-70FB0F25BEE5
published in	Cancer Research
issue	wds:Q72066829-9856E202-2BC2-405E-9789-DD16FDB0D15D
volume	wds:Q72066829-AD00BE1D-5404-4692-BC3B-BDEE94A08E34
issue	1
volume	53
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72066829
is cites work of	Lung cancer screening: from imaging to biomarker Serum biomarkers in interstitial lung diseases Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer A novel immunoassay for the quantization of CYFRA 21-1 in human serum. Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer Tumour markers: An overview Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease Cytokeratins 8 and 19 in the mouse placental development Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1. Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer Clinical significance of serum CYFRA 21-1 in gastric cancer CYFRA 21-1 as a tumor marker used in measuring the serum fragment of cytokeratin subunit 19 by immunoradiometric assay Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay Role of p53 and β-catenin Mutations in Conjunction with CK19 Expression on Early Tumor Recurrence and Prognosis of Hepatocellular Carcinoma Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? Cytokeratin 19 fragment in serum and tissues of patients with pancreatic diseases Clinical usefulness of CYFRA assay in diagnosing lung cancer: measurement of serum cytokeratin fragment. Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review Predictors of sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseases The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer Serum HE4 as a diagnostic and prognostic marker for lung cancer Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries. Efficacy of auxiliary therapy with Danggui Buxue Decoction No.1 in treating patients of non-small cell lung cancer at peri-operational stage Serum cytokeratin 19 fragment, CK19-2G2, as a newly identified biomarker for lung cancer Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer Keratin 19 expression correlates with poor prognosis in breast cancer Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis Serum Dickkopf-1 (DKK1) is significantly lower in patients with lung cancer but is rapidly normalized after treatment High expression level of BLCA-4 correlates with poor prognosis in human bladder cancer Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers. A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software